pioglitazone has been researched along with D-fructopyranose in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 3 (8.33) | 29.6817 |
| 2010's | 25 (69.44) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, N; Ebara, T; Hirano, T; Hozumi, T; Ishida, Y; Kazumi, T; Odaka, H; Yoshino, G | 1 |
| Ikeda, H; Nomura, C; Odaka, H; Suzuki, M | 1 |
| Kotchen, TA; Reddy, S; Zhang, HY | 1 |
| Fujiyama, K; Ikeda, T | 1 |
| Ito, T; Matsui, H; Nishimoto, Y; Okumura, K; Tomida, T | 1 |
| Han, YQ; Koshinaka, K; Ohsawa, I; Oshida, Y; Sato, Y | 1 |
| Carranza, A; Mayer, MA; Peredo, HA; Puyó, AM | 1 |
| Hao, Y; Hou, L; Liu, X; Luo, D; Zhang, S; Zheng, M | 1 |
| Hu, QH; Kong, LD; Li, JM; Li, YC | 1 |
| Aragno, M; Boccuzzi, G; Castiglia, S; Collino, M; Fantozzi, R; Miglio, G; Thiemermann, C; Tomasinelli, C | 1 |
| Chang, CJ; Liou, SS; Liu, IM; Tzeng, TF | 1 |
| Dong, C; Hou, L; Hou, X; Liu, X; Luo, D; Wang, M; Xu, S | 1 |
| Chang, CJ; Chang, YS; Liu, IM; Tzeng, TF | 1 |
| Chen, YW; Huang, CL; Huang, NK; Huang, WJ; Kuo, TY; Lin, RJ; Yang, JM; Yang, YC | 1 |
| Dong, SQ; Liu, XP; Luo, DZ; Pei, JJ; Sun, MH; Sun, ZJ; Xu, S; Yin, QQ; You, L | 1 |
| Bhansali, S; Malhotra, S; Pandhi, P; Shafiq, N; Sharma, S; Singh, AP; Singh, I; Singh, PK | 1 |
| Curtin, CR; Ford, L; Heald, D; Manitpisitkul, P; Shalayda, K; Wang, SS | 1 |
| Chen, H; Haseeb, S; He, X; Li, H; Li, W; Ni, Y; Xu, M; Zhou, Y | 1 |
| Abdallah, DM; El-Denshary, ES; Ibrahim, SM | 1 |
| Abd El-Haleim, EA; Bahgat, AK; Saleh, S | 1 |
| Achike, FI; Kunasegaran, T; Murugan, DD; Mustafa, MR | 2 |
| Ali, EF; Mahdi, EA; Mahmoud, FA; Mostafa-Hedeab, G; Shahataa, MG | 1 |
| Gad, ES; Moustafa, YM; Zaitone, SA | 1 |
| Chen, IC; Chen, LW; Fu, MH; Hung, CY; Liu, WC; Tain, YL; Wu, CW; Wu, KLH | 1 |
| Cannizzo, B; Castro, C; Cejas, J; García, R; Quesada, I; Redondo, A | 1 |
| Abdo, K; Andrews, P; Bril, F; Cusi, K; Frye, RF; Garrett, TJ; Guingab, J; Jose, D; Kalavalapalli, S; Koelmel, JP; Li, WY; Sunny, NE; Yost, RA | 1 |
| Gameil, NM; Shawky, NM; Shehatou, GSG; Suddek, GM | 1 |
| Chan, JYH; Chen, LW; Fu, MH; Hirase, H; Ho, YH; Hung, CY; Kung, YC; Lee, WC; Leu, S; Liang, CK; Liu, WC; Tain, YL; Wu, CW; Wu, KLH | 1 |
| Chen, IC; Hung, CY; Lin, IC; Tain, YL; Wu, CW; Wu, KLH | 1 |
| Kong, LD; Li, JM; Wang, SJ; Wen, SY; Xu, Q; Yu, R; Zhang, LP; Zhang, XY | 1 |
| Chen, L; Gao, YS; Li, YH; Sun, Y; Wang, M; Wang, Y; Wu, MY; Yang, JM; Zhang, SJ; Zhang, XL; Zheng, FJ; Zhou, L; Zhou, YM | 1 |
| Chen, IC; Fu, MH; Hung, CY; Lee, YC; Liang, CK; Liu, WC; Tain, YL; Wu, CW; Wu, CY; Wu, KLH | 1 |
| Asker, ME; Eissa, RG; Mohamed, HE; Shaheen, MA; Younis, NN | 1 |
| El-Fayoumi, S; Fahmy, A; Ibrahim, I; Mahmoud, A; Mansour, R | 1 |
| Bae, J; Cha, BS; Kang, ES; Lee, BW; Lee, JY; Lee, M; Lee, YH; Shin, E | 1 |
1 trial(s) available for pioglitazone and D-fructopyranose
| Article | Year |
|---|---|
Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Female; Fructose; Humans; Hypoglycemic Agents; Male; Metformin; Pioglitazone; Tandem Mass Spectrometry; Thiazolidinediones; Time Factors; Topiramate; Young Adult | 2014 |
35 other study(ies) available for pioglitazone and D-fructopyranose
| Article | Year |
|---|---|
VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
Topics: Animals; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Disease Models, Animal; Energy Intake; Fatty Acids, Nonesterified; Fructose; Hypoglycemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Obesity; Pioglitazone; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Thinness; Triglycerides | 1996 |
Effect of an insulin sensitizer, pioglitazone, on hypertension in fructose-drinking rats.
Topics: Animals; Blood Glucose; Blood Pressure; Disease Models, Animal; Drinking; Fructose; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Pioglitazone; Rats; Rats, Inbred WKY; Thiazoles; Thiazolidinediones; Time Factors; Triglycerides | 1997 |
Increasing insulin sensitivity lowers blood pressure in the fructose-fed rat.
Topics: Acetylcholine; Adipocytes; Animals; Blood Pressure; Fructose; Glucose; Insulin; Insulin Resistance; Male; Norepinephrine; Pioglitazone; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Vasoconstrictor Agents; Vasodilation | 1997 |
The effect of pioglitazone on glucose metabolism and insulin uptake in the perfused liver and hindquarter of high-fructose-fed rats.
Topics: Animals; Fructose; Glucose; Hypoglycemic Agents; Insulin; Liver; Male; Muscles; Perfusion; Pioglitazone; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones | 1998 |
Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Dietary Sucrose; Fructose; Hypertension; Hypoglycemic Agents; Kidney Cortex; Kidney Medulla; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pioglitazone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride, Dietary; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2002 |
The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats.
Topics: Animals; Body Weight; Dietary Carbohydrates; Eating; Enzyme Inhibitors; Fructose; Glucose; Glucose Clamp Technique; Hypoglycemic Agents; Insulin; Male; Muscle, Skeletal; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones | 2004 |
Pioglitazone and losartan modify hemodynamic and metabolic parameters and vascular prostanoids in fructose-overloaded rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Blood Vessels; Dinoprostone; Drug Synergism; Epoprostenol; Fructose; Hemodynamics; In Vitro Techniques; Losartan; Male; Mesentery; Pioglitazone; PPAR gamma; Prostaglandins; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thromboxanes; Triglycerides | 2008 |
Effect of pioglitazone on insulin resistance in fructose-drinking rats correlates with AGEs/RAGE inhibition and block of NADPH oxidase and NF kappa B activation.
Topics: Animals; Brain; Drinking; Fructose; Gene Expression Regulation, Enzymologic; Glycation End Products, Advanced; Insulin Resistance; Male; Memory Disorders; NADPH Oxidases; NF-kappa B; Pioglitazone; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazolidinediones | 2010 |
Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats.
Topics: Animals; Curcumin; Dietary Carbohydrates; Extracellular Signal-Regulated MAP Kinases; Fatty Liver; Fructose; Hypertriglyceridemia; Insulin Resistance; Leptin; Liver; Male; Pioglitazone; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazolidinediones | 2010 |
Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation.
Topics: Administration, Oral; Animals; Cholesterol, Dietary; Dietary Carbohydrates; Disease Models, Animal; Fructose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatitis; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; Lipids; Liver; Male; Neutrophil Infiltration; Overweight; Phosphorylation; Pioglitazone; PPAR gamma; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazolidinediones; Time Factors; Tumor Necrosis Factor-alpha | 2010 |
Angelica acutiloba root attenuates insulin resistance induced by high-fructose diet in rats.
Topics: Angelica; Animals; Body Weight; Fructose; Glucose Tolerance Test; Glucose Transporter Type 4; Glycogen; Homeostasis; Hypoglycemic Agents; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Lipids; Liver; Male; Phosphoenolpyruvate Carboxykinase (GTP); Pioglitazone; Plant Extracts; Plant Roots; Rats, Wistar; Thiazolidinediones | 2011 |
Effect of pioglitazone on altered expression of Aβ metabolism-associated molecules in the brain of fructose-drinking rats, a rodent model of insulin resistance.
Topics: Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Down-Regulation; Drinking; Fructose; Gene Expression Regulation; Hippocampus; Insulin; Insulin Resistance; Male; Peptide Fragments; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones | 2011 |
Beneficial impact of Zingiber zerumbet on insulin sensitivity in fructose-fed rats.
Topics: Animals; Fructose; Hypoglycemic Agents; Insulin Resistance; Male; Pioglitazone; Plant Extracts; Rats; Rats, Wistar; Thiazolidinediones; Zingiberaceae | 2012 |
The role of ribosylated-BSA in regulating PC12 cell viability.
Topics: Animals; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Fructose; Glucose; Glycation End Products, Advanced; Glycosylation; Imidazoles; Lysine; Mice; Molecular Weight; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Pioglitazone; Polysaccharides; PPAR gamma; Pyrimidines; Rats; Ribose; Rosiglitazone; Serum Albumin, Bovine; Thiazolidinediones | 2012 |
Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats.
Topics: Analysis of Variance; Animals; Brain Diseases; Fructose; Hyperinsulinism; Insulin; Insulin Resistance; Male; Maze Learning; Memory; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Reactive Oxygen Species; Thiazolidinediones; Thiobarbituric Acid Reactive Substances | 2013 |
Effect of a deacyl gymnemic acid on glucose homeostasis & metabolic parameters in a rat model of metabolic syndrome.
Topics: Animals; Blood Glucose; Body Weight; Disease Models, Animal; Female; Fructose; Glucose; Glucose Tolerance Test; Homeostasis; Hypoglycemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Pioglitazone; Rats; Rats, Wistar; Saponins; Systole; Thiazolidinediones; Triglycerides; Triterpenes | 2013 |
Simultaneous determination of phentermine and topiramate in human plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study.
Topics: Chromatography, Liquid; Fructose; Humans; Ions; Phentermine; Pioglitazone; Plasma; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Thiazolidinediones; Topiramate | 2015 |
Geraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress status.
Topics: Acyclic Monoterpenes; Adiponectin; Adipose Tissue; Adiposity; Animals; Blood Pressure; Body Weight; Drug Interactions; Fructose; Glucose; Glycated Hemoglobin; Homeostasis; Inflammation; Interleukin-1beta; Liver; Male; Metabolic Syndrome; Oxidative Stress; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Reactive Nitrogen Species; Terpenes; Thiazolidinediones; Transcription, Genetic; Tumor Necrosis Factor-alpha; Uric Acid | 2015 |
Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Topics: Adiponectin; Adipose Tissue; Animals; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Fenofibrate; Fructose; Gene Expression Regulation; Glutathione; Homeostasis; Insulin; Leptin; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Pioglitazone; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
The bioflavonoid quercetin synergises with PPAR-γ agonist pioglitazone in reducing angiotensin-II contractile effect in fructose-streptozotocin induced diabetic rats.
Topics: Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; Fructose; Male; Muscle Contraction; Pioglitazone; PPAR gamma; Quercetin; Rats; Rats, Sprague-Dawley; Thiazolidinediones | 2016 |
Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats.
Topics: Animals; Benzimidazoles; Benzoates; Blood Glucose; Drug Therapy, Combination; Fructose; Hypoglycemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Pioglitazone; Rats; Rats, Sprague-Dawley; Telmisartan; Thiazolidinediones; Treatment Outcome | 2016 |
Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats.
Topics: Amyloid beta-Peptides; Animals; Cognition; Down-Regulation; Drug Therapy, Combination; Exenatide; Fructose; Hippocampus; Insulin Resistance; Male; Maze Learning; Memory Disorders; Microglia; Nootropic Agents; Peptides; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones; Venoms | 2016 |
Quercetin and pioglitazone synergistically reverse endothelial dysfunction in isolated aorta from fructose-streptozotocin (F-STZ)-induced diabetic rats.
Topics: Animals; Aorta; Diabetes Mellitus, Experimental; Drug Synergism; Endothelium, Vascular; Fructose; Male; Nitric Oxide; Oxidative Stress; Pioglitazone; Quercetin; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Vasodilation | 2017 |
Oral pioglitazone ameliorates fructose-induced peripheral insulin resistance and hippocampal gliosis but not restores inhibited hippocampal adult neurogenesis.
Topics: Administration, Oral; Adult Stem Cells; Animals; Fructose; Gliosis; Hippocampus; Hypoglycemic Agents; Insulin Resistance; Male; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Pioglitazone; Rats; Rats, Inbred WKY; Thiazolidinediones | 2018 |
Vascular dysfunction elicited by a cross talk between periaortic adipose tissue and the vascular wall is reversed by pioglitazone.
Topics: Adipose Tissue; Animals; Aorta; Apolipoproteins E; Blood Glucose; Blood Vessels; Fructose; Hypoglycemic Agents; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Pioglitazone; Plaque, Atherosclerotic; Signal Transduction; Thiazolidinediones; Vascular Diseases | 2018 |
Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis.
Topics: Adipose Tissue; Amino Acids, Branched-Chain; Animals; Citric Acid Cycle; Diet; Female; Fructose; Humans; Hypoglycemic Agents; Insulin Resistance; Ketones; Male; Mice, Inbred C57BL; Middle Aged; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Pioglitazone; Pyruvic Acid | 2018 |
Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats.
Topics: Animals; Aorta, Thoracic; Blood Glucose; Body Weight; C-Reactive Protein; Dyslipidemias; Fatty Liver; Fructose; Hypoglycemic Agents; Insulin Resistance; Isothiocyanates; L-Lactate Dehydrogenase; Male; Pioglitazone; Rats, Sprague-Dawley; Sulfoxides | 2019 |
Pioglitazone reversed the fructose-programmed astrocytic glycolysis and oxidative phosphorylation of female rat offspring.
Topics: Animals; Astrocytes; Dietary Sugars; DNA, Mitochondrial; Female; Fetal Development; Fructose; Glucose Transporter Type 1; Glycolysis; Hypoglycemic Agents; Mitochondria; Oxidative Phosphorylation; Pioglitazone; Pregnancy; Prenatal Exposure Delayed Effects; Primary Cell Culture; Rats; Receptor, Insulin; Transcription Factors | 2019 |
High fructose diet induces early mortality via autophagy factors accumulation in the rostral ventrolateral medulla as ameliorated by pioglitazone.
Topics: Animals; Autophagy; Autophagy-Related Protein 12; Beclin-1; Diet; Fructose; Hypoglycemic Agents; Insulin; Male; Medulla Oblongata; Metabolic Syndrome; Microtubule-Associated Proteins; Mortality; Pioglitazone; Proteins; Rats, Wistar | 2019 |
Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
Topics: Animals; Doublecortin Protein; Dysbiosis; Fatty Acids, Volatile; Fructose; Gastrointestinal Microbiome; Hippocampus; Inflammasomes; Inflammation; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Neuroimmunomodulation; Pioglitazone | 2019 |
Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Topics: Animals; Bupleurum; Diet, High-Fat; Disease Models, Animal; Drugs, Chinese Herbal; Fructose; Humans; Intestinal Mucosa; Lipid Metabolism; Liver; Liver Function Tests; Male; Non-alcoholic Fatty Liver Disease; Paeonia; Pioglitazone; Plant Roots; Rats; Rats, Sprague-Dawley; Scutellaria | 2019 |
Maternal high fructose-induced hippocampal neuroinflammation in the adult female offspring via PPARγ-NF-κB signaling.
Topics: Animals; Cytokines; Diet; Female; Fructose; Hippocampus; Inflammation; Inflammation Mediators; Male; Microglia; Neurogenic Inflammation; Neurons; NF-kappa B; Pioglitazone; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Signal Transduction | 2020 |
Alleviation of fructose-induced Alzheimer's disease in rats by pioglitazone and decaffeinated green coffee bean extract.
Topics: Alzheimer Disease; Animals; Antioxidants; Coffee; Fructose; Pioglitazone; Plant Extracts; Rats | 2021 |
Pioglitazone Enhances β-Arrestin2 Signaling and Ameliorates Insulin Resistance in Classical Insulin Target Tissues.
Topics: Adipose Tissue; Animals; beta-Arrestin 2; Diet, High-Fat; Disease Models, Animal; Fructose; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Mice; Muscle, Skeletal; Pioglitazone; Signal Transduction | 2021 |
The effects of the voglibose on non-alcoholic fatty liver disease in mice model.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Fructose; Glucose; Glycoside Hydrolase Inhibitors; Inositol; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Pioglitazone | 2022 |